Search results
- Dr. Chen is the Director for the bone marrow transplant program at Massacusetts General Hospital. His research interests mainy revolve around improving the outcomes for patients undergoing autologous and allogeneic stem cell transplantation. He serves as institution and overall principal investigator for many clinical trials.
People also ask
Who is Yi-Bin Chen?
Who is Dr Chen?
Who is Yi Chen?
Who is Ian Yi (易柏辰) ?
Who is Bin Chen?
Who is Yiming Chen?
Dr. Chen is the Director for the BMT program at MGH. His research interests mainly revolve around improving the outcomes for patients undergoing autologous and allogeneic stem cell transplantation. He serves as institution and overall principal investigator for many clinical trials.
Articles 1–20. Professor, Harvard Medical School - Cited by 16,464 - Bone Marrow Transplantation.
Yi-Bin Chen, MD, MS Dr. Chen leads the MGH Blood and Marrow Transplant center. He divides his time between patient care, clinical research and program administration with a focus on patients undergoing bone marrow/stem cell transplantation.
Mar 10, 2023 · Yi-Bin Chen, MD is the Director of the Hematopoietic Cell Transplant and Cell Therapy Program at Massachusetts General Hospital. Yi-Bin is the inaugural Allan Rogers, Jr. and Cara J. Rogers Endowed Chair and an Associate Professor at Harvard Medical School.
Dr. Chen is a world leader in tolerance science and led original clinical trials involving all aspects of BMT, including conditioning regimens, alternative graft sources, novel approaches concerning the prevention and therapy of acute and chronic graft-vs-host disease (GVHD) and the use of maintenance therapies after BMT.
Yi-Bin Chen's 274 research works with 9,730 citations and 5,919 reads, including: Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia.
